Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis (Q104269351)
Jump to navigation
Jump to search
scientific article published on 07 December 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis |
scientific article published on 07 December 2020 |
Statements
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis (English)
Liliana Schaefer
Stephanie Schwalm
Sandra Beyer
Redona Hafizi
Sandra Trautmann
Gerd Geisslinger
David R Adams
Susan Pyne
Nigel Pyne
Andrea Huwiler
Josef Pfeilschifter
7 December 2020